Avanti Biosciences, Inc. a preclinical-stage biopharmaceutical company lead by CFB BioEntrepreneur-in-Residence Dr. Gian Luca Araldi, has announced that the National Institute of Aging (NIA) has awarded the Company an SBIR fast-track grant of up to $1,930,000 to support the company’s small molecule Alzheimer’s disease (AD) over the next 3 years.
Learn MoreThe latest CFB Newsletter has been released – Highlights include major client funding and contracts, the expansion of the LIBH pipeline, and CFB leadership appearing before congress to promote comprehensive, early technology development programs.
Learn MoreCall for Papers: The 13th International Conference & Expo on Emerging Technologies for a Smarter World (CEWIT2017) November 7 & 8, 2017 The Center of Excellence in Wireless and Information Technology (CEWIT) at Stony Brook University Stony Brook, NY, USA …
Learn MoreAwards Support Innovative Research Collaborations Between Academic Faculty and Regional Bioscience Companies The Center for Biotechnology at Stony Brook University has announced the recipients of the 2017-2018 Applied Research & Development (ARAD) awards. The ARAD Program is designed to help …
Learn MoreInnovative phase-0 proof-of-concept center continues advancement of commercially promising biomedical innovations. The Center for Biotechnology at Stony Brook University, on behalf of the Long Island Bioscience Hub (LIBH), announced the recipients of the fourth round of funded projects under the …
Learn MoreDr. Sasha Levy, Marsha Laufer Endowed Assistant Professor of Physical and Quantitative Biology for the Laufer Center and the Department of Biochemistry & Cell Biology at Stony Brook University, recently had an article published in Nature Communications related to his …
Learn More